EU gives nod to joint venture

Article

In what could be an example of how European regulators like to see things done, the European Union has approved a joint venture between Europe-based companies Draegerwerk and Siemens Medical Solutions. Draeger will contribute its entire medical division

In what could be an example of how European regulators like to see things done, the European Union has approved a joint venture between Europe-based companies Draegerwerk and Siemens Medical Solutions. Draeger will contribute its entire medical division to the joint venture, which will address the acute hospital care marketplace. Siemens will contribute its patient monitoring systems. The result will be called Draeger Medical-A Draeger and Siemens Company. Ownership will be split 65% Draeger and 35% Siemens.

Under the deal, Siemens will sell its Life Support Systems unit, composed of anesthesia and ventilation devices, to a third party. The joint venture will continue to supply open data interfaces to enable integration of its products and devices with those of other companies. The joint venture's sales organization will work closely with that of Siemens, especially in developing cross-departmental solutions for hospitals and supporting key accounts. In cooperation with Siemens and through the use of the Siemens software platforms syngo and Soarian as basic architecture, the joint venture will develop, produce, and market critical care IT solutions for optional integration into more comprehensive healthcare solutions, according to Siemens.

Recent Videos
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
Related Content
© 2025 MJH Life Sciences

All rights reserved.